Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,262,582 papers from all fields of science
Search
Sign In
Create Free Account
Topotecan 4 MG Injection [Hycamtin]
Known as:
Hycamtin 4 MG Injection
, TOPOTECAN HYDROCHLORIDE 4 mg in 4 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HYCAMTIN]
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
Hycamtin
Hydrochloric Acid
Injection
Mannitol
Expand
Broader (1)
Topotecan 4 MG Injection
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Image‐guided thermosensitive liposomes for focused ultrasound drug delivery: Using NIRF‐labelled lipids and topotecan to visualise the effects of hyperthermia in tumours
M. Centelles
,
Michael Wright
,
+6 authors
M. Thanou
Journal of Controlled Release
2018
Corpus ID: 21686888
2015
2015
Camptothecin and taxol – from nature to bench to bedside
M. Wani
2015
Corpus ID: 71745167
Camptothecin (CPT) and taxol are secondary metabolites found, respectively, in the wood bark of Camptotheca acuminata, a native…
Expand
2011
2011
A prospective phase II study of topotecan (Hycamtin®) and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
N. Manci
,
C. Marchetti
,
+7 authors
P. B. Panici
Gynecologic Oncology
2011
Corpus ID: 20165956
2006
2006
Las plantas como fuente de compuestos antineoplásicos. Revisión
Elisa Vega-Avila
,
R. Velasco-Lezama
,
M. Jiménez-Estrada
2006
Corpus ID: 74546402
), vincristina (Oncovin ® ), vinolrebina (Navelbine ® ), vindesina (Eldisine ® ), etoposido (VP-16®), teniposido (VM-26…
Expand
2006
2006
Effects of topotecan treatment on nasal, buccal, and lingual mucosa in the rabbit: light and transmission electron microscopic evaluation
N. Bayar Muluk
,
F. Kaymaz
,
A. Çakar
European Archives of Oto-Rhino-Laryngology
2006
Corpus ID: 13252478
Anticancer agents may cause side effects and some of which may be dose dependant. It is important for clinicians to see the…
Expand
2001
2001
Acute Toxicity and Changes in Quality of Life during a Combined Radio-Chemotherapy of Glioblastomas with Topotecan (Hycamtin®)
M. Gross
,
Riglef Altscher
,
+4 authors
R. Engenhart-Cabillic
Strahlentherapie und Onkologie (Print)
2001
Corpus ID: 693992
Background: Because of the pronounced radioresistance of glioblastoma multiforme the prognosis of this disease remains poor…
Expand
2000
2000
A phase II trial of Topotecan (Hycamtin®) with Ifosfamide (Duvaxan®) plus Mesna (Mesnex®) as first line treatment in patients (pts) with small cell lung cancer (SCLC). A preliminary report
M. Ventriglia
,
L. Cabrera
,
M. Maidana
,
S. Vigo
,
M. Cilurzo
,
R. Estévez
2000
Corpus ID: 71790199
1999
1999
Stability of topotecan infusion solutions in polyvinylchloride bags and elastomeric portable infusion devices
I. Krämer
,
J. Thiesen
1999
Corpus ID: 72255995
Purpose. The purpose of this study was to determine the physicochemical stability of topotecan after reconstitution and after…
Expand
Highly Cited
1997
Highly Cited
1997
126 Evaluation of topotecan (Hycamtin™) in relapsed small cell lung cancer (SCLC). A multicentre phase II study
A. Depierre
,
J. Pawel
,
+9 authors
M. Marangolo
1997
Corpus ID: 57297354
1997
1997
Topotecan (Hycamtin™) in small cell lung cancer (SCLC) after failure of first line therapy: Multicentre phase II study
J. Pawel
,
A. Deplerre
,
+9 authors
M. Marangolo
1997
Corpus ID: 71224780
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE